MT110
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MT110, covering 2015-01-13 to 2015-01-13. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer [Phase 1]